Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sadaaki Nishimura

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Carcinogenesis|April 3, 2020
Serine threonine kinase 11/liver kinase B1 mutation in sporadic scirrhous-type gastric cancer cellsSadaaki Nishimura, Masakazu Yashiro, Tomohiro Sera, et al.
Cancer Medicine|November 3, 2022
Establishment of a gastric cancer cell line with high microsatellite instability, OCUM-13, derived from Borrmann type-2 primary tumorYurie Yamamoto, Go Masuda, Shuhei Kushiyama, et al.
Oncology Letters|December 2, 2020
SDF1α/CXCR4 axis may be associated with the malignant progression of gastric cancer in the hypoxic tumor microenvironmentMasakazu Yashiro, Haruhito Kinoshita, Gen Tsujio, et al.
European Surgical Research. Europaische Chirurgische Forschung. Recherches Chirurgicales Europeennes|April 21, 2021
Asporin Expression on Stromal Cells and/or Cancer Cells Might Be A Useful Prognostic Marker in Patients with Diffuse-Type Gastric CancerMasakazu Yashiro, Tsuyoshi Hasegawa, Yurie Yamamoto, et al.
Cancer Letters|September 2, 2021
EMMPRIN in extracellular vesicles from peritoneal mesothelial cells stimulates the invasion activity of diffuse-type gastric cancer cellsAtsushi Sugimoto, Tomohisa Okuno, Yuichiro Miki, et al.
Anticancer Research|December 8, 2019
The Clinicopathological Significance of the CXCR2 Ligands, CXCL1, CXCL2, CXCL3, CXCL5, CXCL6, CXCL7, and CXCL8 in Gastric CancerYurie Yamamoto, Kenji Kuroda, Tomohiro Sera, et al.
Plos One|April 4, 2022
CXCR2 signaling might have a tumor-suppressive role in patients with cholangiocarcinomaYurie Yamamoto, Atsushi Sugimoto, Koji Maruo, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 4, 2018
[A Case of Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis Treated Successfully with Multidisciplinary Therapy Including Preoperative Stereotactic Body Radiotherapy(SBRT)]Sadaaki Nishimura, Akira Tomokuni, Shogo Kobayashi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 4, 2018
[Surgical Resection of Peritoneal Recurrence of Hepatocellular Carcinoma with Endoscopic Fluorescence Imaging System]Sadaaki Nishimura, Akira Tomokuni, Shogo Kobayashi, et al.
Molecular and Clinical Oncology|April 5, 2021
Clinicopathologic significance of TROP2 and phospho-TROP2 in gastric cancerShuhei Kushiyama, Masakazu Yashiro, Yurie Yamamoto, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Carcinogenesis|April 3, 2020
Serine threonine kinase 11/liver kinase B1 mutation in sporadic scirrhous-type gastric cancer cellsSadaaki Nishimura, Masakazu Yashiro, Tomohiro Sera, et al.
Cancer Medicine|November 3, 2022
Establishment of a gastric cancer cell line with high microsatellite instability, OCUM-13, derived from Borrmann type-2 primary tumorYurie Yamamoto, Go Masuda, Shuhei Kushiyama, et al.
Oncology Letters|December 2, 2020
SDF1α/CXCR4 axis may be associated with the malignant progression of gastric cancer in the hypoxic tumor microenvironmentMasakazu Yashiro, Haruhito Kinoshita, Gen Tsujio, et al.
European Surgical Research. Europaische Chirurgische Forschung. Recherches Chirurgicales Europeennes|April 21, 2021
Asporin Expression on Stromal Cells and/or Cancer Cells Might Be A Useful Prognostic Marker in Patients with Diffuse-Type Gastric CancerMasakazu Yashiro, Tsuyoshi Hasegawa, Yurie Yamamoto, et al.
Cancer Letters|September 2, 2021
EMMPRIN in extracellular vesicles from peritoneal mesothelial cells stimulates the invasion activity of diffuse-type gastric cancer cellsAtsushi Sugimoto, Tomohisa Okuno, Yuichiro Miki, et al.
Anticancer Research|December 8, 2019
The Clinicopathological Significance of the CXCR2 Ligands, CXCL1, CXCL2, CXCL3, CXCL5, CXCL6, CXCL7, and CXCL8 in Gastric CancerYurie Yamamoto, Kenji Kuroda, Tomohiro Sera, et al.
Plos One|April 4, 2022
CXCR2 signaling might have a tumor-suppressive role in patients with cholangiocarcinomaYurie Yamamoto, Atsushi Sugimoto, Koji Maruo, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 4, 2018
[A Case of Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis Treated Successfully with Multidisciplinary Therapy Including Preoperative Stereotactic Body Radiotherapy(SBRT)]Sadaaki Nishimura, Akira Tomokuni, Shogo Kobayashi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 4, 2018
[Surgical Resection of Peritoneal Recurrence of Hepatocellular Carcinoma with Endoscopic Fluorescence Imaging System]Sadaaki Nishimura, Akira Tomokuni, Shogo Kobayashi, et al.
Molecular and Clinical Oncology|April 5, 2021
Clinicopathologic significance of TROP2 and phospho-TROP2 in gastric cancerShuhei Kushiyama, Masakazu Yashiro, Yurie Yamamoto, et al.
Pageof 3